KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Exact Sciences (EXAS) Shares Outstanding (Diluted Average) (2019 - 2025)

Historic Shares Outstanding (Diluted Average) for Exact Sciences (EXAS) over the last 11 years, with Q4 2025 value amounting to $188.7 million.

  • Exact Sciences' Shares Outstanding (Diluted Average) rose 243.82% to $188.7 million in Q4 2025 from the same period last year, while for Dec 2025 it was $188.7 million, marking a year-over-year increase of 243.82%. This contributed to the annual value of $188.7 million for FY2025, which is 243.82% up from last year.
  • Exact Sciences' Shares Outstanding (Diluted Average) amounted to $188.7 million in Q4 2025, which was up 243.82% from $189.3 million recorded in Q3 2025.
  • Over the past 5 years, Exact Sciences' Shares Outstanding (Diluted Average) peaked at $189.3 million during Q3 2025, and registered a low of $169.4 million during Q1 2021.
  • Its 5-year average for Shares Outstanding (Diluted Average) is $180.0 million, with a median of $180.2 million in 2023.
  • Its Shares Outstanding (Diluted Average) has fluctuated over the past 5 years, first surged by 1453.78% in 2021, then surged by 39.11% in 2024.
  • Exact Sciences' Shares Outstanding (Diluted Average) (Quarter) stood at $171.3 million in 2021, then grew by 2.92% to $176.4 million in 2022, then rose by 2.15% to $180.1 million in 2023, then grew by 2.25% to $184.2 million in 2024, then grew by 2.44% to $188.7 million in 2025.
  • Its Shares Outstanding (Diluted Average) was $188.7 million in Q4 2025, compared to $189.3 million in Q3 2025 and $188.9 million in Q2 2025.